Prophylactic Mastectomy in BRCA1/2 Mutation Carriers and Women at Risk of Hereditary Breast Cancer: Long-Term Experiences at the Rotterdam Family Cancer Clinic

BACKGROUND: BRCA1/2 mutation carriers and women from a hereditary breast(/ovarian) cancer family have a highly increased risk of developing breast cancer (BC). Prophylactic mastectomy (PM) results in the greatest BC risk reduction. Long-term data on the efficacy and sequels of PM are scarce. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Heemskerk-Gerritsen, Bernadette A. M., Brekelmans, Cecile T. M., Menke-Pluymers, Marian B. E., van Geel, Albert N., Tilanus-Linthorst, Madeleine M. A., Bartels, Carina C. M., Tan, Murly, Meijers-Heijboer, Hanne E. J., Klijn, Jan G. M., Seynaeve, Caroline
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Breast Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077910/
https://www.ncbi.nlm.nih.gov/pubmed/17541692
http://dx.doi.org/10.1245/s10434-007-9449-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077910/
https://www.ncbi.nlm.nih.gov/pubmed/17541692
http://dx.doi.org/10.1245/s10434-007-9449-x

Ejemplares similares